重新发现单核细胞系统阻断的纳米颗粒药物输送
Ivan V Zelepukin1,2, Konstantin G Shevchenko3, Sergey M Deyev4
1Department of Medicinal Chemistry, Uppsala University, 751 23, Uppsala, Sweden. ivan.zelepukin@ilk.uu.se.
Nature communications
|May 22, 2024
概括
暂时阻断单核细胞系统 (MPS) 增强了纳米粒子循环和瘤输送. 这种重新发现的技术显示了改善临床应用中纳米药物疗效的前景.
科学领域:
- 纳米医学是一种纳米医学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 单核细胞系统 (MPS) 吸收纳米粒子限制了治疗效果.
- 临时MPS封锁是克服这一局限性的策略.
- 历史上,这种方法在临床实践中一直被忽视.
研究的目的:
- 验证时间MPS封锁对改善纳米粒子输送的有效性.
- 审查MPS封锁策略的历史演变.
- 阐明MPS封锁背后的潜在机制及其临床转化.
主要方法:
- 关于MPS封锁和纳米粒子传递的已公布数据的元分析.
- 对MPS封锁技术的历史审查.
- 分析潜在的协同作用机制.
主要成果:
- 分析证实,MPS阻塞增强了纳米粒子的血液循环.
- 证据支持瘤中纳米粒子积累的改善.
- 介绍了对该技术长达一个世纪的发展的全面理解.
结论:
- 暂时MPS阻塞是改善纳米药物输送的验证方法.
- 了解它的演变和机制是临床翻译的关键.
- 进一步的研究应侧重于成功临床应用所必需的特征.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
12.4K
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
8.7K
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...